Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Maeda

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Annals of the Rheumatic Diseases|November 9, 2019
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese populationToshihiro Kishikawa, Yuichi Maeda, Takuro Nii, et al.
RMD Open|August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
Rheumatology (Oxford, England)|May 9, 2024
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort studyRyu Watanabe, Kosuke Ebina, Takaho Gon, et al.
Modern Rheumatology|March 19, 2025
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
International Journal of Rheumatic Diseases|March 5, 2024
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort studyIku Shirasugi, Akira Onishi, Keisuke Nishimura, et al.
Ebiomedicine|July 26, 2020
Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cellsDaisuke Takahashi, Naomi Hoshina, Yuma Kabumoto, et al.
Annals of the Rheumatic Diseases|June 26, 2022
Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic componentYuya Shirai, Yoshimitsu Nakanishi, Akari Suzuki, et al.
The EMBO Journal|September 4, 2023
Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndromeHachiro Konaka, Yasuhiro Kato, Toru Hirano, et al.
Translational Stroke Research|June 14, 2022
Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association StudyShogo Dofuku, Kyuto Sonehara, Satoru Miyawaki, et al.
International Journal of Rheumatic Diseases|July 1, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort StudyKosuke Ebina, Yuki Etani, Yasutaka Okita, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|November 9, 2019
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese populationToshihiro Kishikawa, Yuichi Maeda, Takuro Nii, et al.
RMD Open|August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
Rheumatology (Oxford, England)|May 9, 2024
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort studyRyu Watanabe, Kosuke Ebina, Takaho Gon, et al.
Modern Rheumatology|March 19, 2025
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
International Journal of Rheumatic Diseases|March 5, 2024
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort studyIku Shirasugi, Akira Onishi, Keisuke Nishimura, et al.
Ebiomedicine|July 26, 2020
Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cellsDaisuke Takahashi, Naomi Hoshina, Yuma Kabumoto, et al.
Annals of the Rheumatic Diseases|June 26, 2022
Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic componentYuya Shirai, Yoshimitsu Nakanishi, Akari Suzuki, et al.
The EMBO Journal|September 4, 2023
Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndromeHachiro Konaka, Yasuhiro Kato, Toru Hirano, et al.
Translational Stroke Research|June 14, 2022
Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association StudyShogo Dofuku, Kyuto Sonehara, Satoru Miyawaki, et al.
International Journal of Rheumatic Diseases|July 1, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort StudyKosuke Ebina, Yuki Etani, Yasutaka Okita, et al.
Pageof 8